GGrantIndex
← Leaderboards

Abass Alavi

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗
$5,424,013
Attributed
$5,424,013
Total exposure
11
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2005–07
$2M$1.5M$1M$500K$0
'05
'06
'07

Funding mix

By agency

NIH$5,424,013 · 11

By mechanism

R01$3,799,079 · 2
T32$928,125 · 1
M01$541,142 · 5
R21$155,667 · 1
P01$0 · 1
U54$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchHuman SubjectPositron Emission TomographyBioimaging /Biomedical ImagingHuman Therapy EvaluationMonoclonal AntibodyNonhodgkin'S LymphomaIodineDiagnosis Design /EvaluationNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radionuclide TherapyClinical Trial Phase INeoplasm /Cancer Relapse /RecurrenceCombination Cancer TherapyDrug Screening /EvaluationMagnetic Resonance ImagingRadiopharmacologyRadionuclidesGlucose TransportRadiation Therapy DosageDeoxyglucoseDiagnosis Quality /StandardHistopathologyMedical Complication

Grant awards (33)

Training in Cancer Imaging with Novel Techniques$205,318
T32 · FY2007 · CA · contact PI
Training in Cancer Imaging with Novel Techniques$169,424
T32 · FY2006 · CA · contact PI
FDG-PET Imaging in painful Hip Prosthesis$519,638
R01 · FY2005 · AR
FDG-PET Imaging in Complicated Diabetic Foot$396,250
R01 · FY2005 · DK
Training in Cancer Imaging with Novel Techniques$159,672
T32 · FY2005 · CA
EVALUATION OF MULTIMODALITY BREAST IMAGING: PROJECT 3$2,045
M01 · FY2005 · RR
FDG-PET Imaging in painful Hip Prosthesis$576,939
R01 · FY2004 · AR
FDG-PET Imaging in Complicated Diabetic Foot$396,250
R01 · FY2004 · DK
Training in Cancer Imaging with Novel Techniques$184,219
T32 · FY2004 · CA
Evaluation of multimodality Breast Imaging: Project 3$13,138
M01 · FY2004 · RR
FDG-PET Imaging in Painful Hip Prosthesis$3,906
M01 · FY2004 · RR
FDG-PET Imaging in Complicated Diabetic Foot$355
M01 · FY2004 · RR
FDG-PET Imaging in painful Hip Prosthesis$563,398
R01 · FY2003 · AR
FDG-PET Imaging in Complicated Diabetic Foot$396,250
R01 · FY2003 · DK
Training in Cancer Imaging with Novel Techniques$209,492
T32 · FY2003 · CA
Core--PET and SPECT Imaging$0
U54 · FY2003 · CA
FDG-PET Imaging in painful Hip Prosthesis$559,954
R01 · FY2002 · AR
FDG-PET Imaging in Complicated Diabetic Foot$390,400
R01 · FY2002 · DK
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$124,146
M01 · FY2002 · RR
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$124,146
M01 · FY2002 · RR
LESION STAGING$0
P01 · FY2002 · CA
BIODISTRIBUTION AND CELL KINETICS IN METASTATIC CANCER$155,667
R21 · FY2001 · CA
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$124,146
M01 · FY2001 · RR
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$124,146
M01 · FY2001 · RR
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$0
M01 · FY2001 · RR
LESION STAGING$0
P01 · FY2001 · CA
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$0
M01 · FY2001 · RR
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$25,114
M01 · FY2000 · RR
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$0
M01 · FY2000 · RR
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$0
M01 · FY2000 · RR
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$0
M01 · FY2000 · RR
IODINE 131 ANTI B1 ANTIBODY FOR NONHODGKINS'S LYMPHOMA$0
M01 · FY2000 · RR
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA W/ HUMANIZED IMMU-LL2$0
M01 · FY2000 · RR